Read + Share
Holmberg D, Lagergren J. Risk of gastric and oesophageal adenocarcinoma following discontinuation of
long-term proton-pump inhibitor therapy. J Gastroenterol 2022 Dec 14. doi: 10.1007/s00535-022-01941.
PMID: 36515731
|
 |
|
Holmberg D, Lagergren J. Risk of gastric and oesophageal adenocarcinoma following discontinuation of
long-term proton-pump inhibitor therapy. J Gastroenterol 2022 Dec 14. doi: 10.1007/s00535-022-01941.
PMID: 36515731
|
|
|
|